Celiac Safety Act of 2026
HB9048, titled the Celiac Safety Act of 2026, would amend the Federal Food, Drug, and Cosmetic Act to expand the definition of a “major food allergen” to include gluten-containing grains. Under the bill, the term would cover wheat, rye, barley, and their crossbred hybrids such as triticale. The measure also makes conforming changes to the allergen definition section of the FD&C Act so that gluten-containing grains are treated alongside other major allergens for federal labeling purposes.
The bill would not take effect immediately for all products. Its requirements would apply only to food introduced or delivered into interstate commerce 18 months after enactment, giving manufacturers and distributors time to update ingredient sourcing, labeling, and compliance systems. In practical terms, the bill would affect food producers, processors, importers, and retailers that sell packaged foods subject to federal allergen disclosure rules.
If enacted, HB9048 would amend section 201(qq) of the Federal Food, Drug, and Cosmetic Act, expanding the federal major allergen list and likely triggering new labeling obligations for foods containing gluten-containing grains. The change would affect interstate food commerce and would require affected businesses to identify wheat, rye, barley, and related hybrids more explicitly in allergen disclosures. The 18-month delayed applicability provision would soften the immediate regulatory burden but still create a nationwide compliance shift for the food industry and consumer-facing labeling practices.
The available context suggests generally favorable or protective sentiment around the bill, as reflected in its title and purpose: improving safety for people with celiac disease and gluten-related disorders. There is no recorded committee transcript or vote history in the provided materials, so there is no evidence of formal opposition or amendment debate. The bill appears to be framed as a consumer protection and food transparency measure rather than a controversial policy change.
No specific points of contention are documented in the provided committee or voting materials. Potential areas of debate, based on the bill text, would likely center on the scope of the new allergen definition, the compliance costs for food manufacturers, and whether gluten-containing grains should be treated as a major allergen under federal law. Any concerns would most likely come from regulated food businesses or stakeholders focused on labeling burden, while supporters would likely include celiac disease advocates and consumer safety groups.